1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Pérez-Molina JA, Molina I.

    Chagas disease

    LANCET . 391(10115): 82-94. Nº de citas: 544

    [doi:10.1016/S0140-6736(17)31612-4]

  • Chaves F, Garnacho-Montero J, Del Pozo JL, Bouza E, Capdevila JA, de Cueto M, Domínguez MÁ, Esteban J, Fernández-Hidalgo N, Fernández Sampedro M, Fortún J, Guembe M, Lorente L, Paño JR, Ramírez P, Salavert M, Sánchez M, Vallés J.

    Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC).

    MEDICINA INTENSIVA . 42(1): 5-36.

    [doi:10.1016/j.medin.2017.09.012]

  • Berenguer J, Jarrín I, Pérez-Latorre L, Hontañón V, Vivancos MJ, Navarro J, Téllez MJ, Guardiola JM, Iribarren JA, Rivero-Juárez A, Márquez M, Artero A, Morano L, Santos I, Moreno J, Fariñas MC, Galindo MJ, Hernando MA, Montero M, Cifuentes C, Domingo P, Sanz J, Domíngez L, Ferrero OL, De la Fuente B, Rodríguez C, Reus S, Hernández-Quero J, Gaspar G, Pérez-Martínez L, García C, Force L, Veloso S, Losa JE, Vilaró J, Bernal E, Arponen S, Ortí AJ, Chocarro Á, Teira R, Alonso G, Silvariño R, Vegas A, Geijo P, Bisbe J, Esteban H, González-García J.

    Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant.

    Open forum infectious diseases . 5(1): . Nº de citas: 17

    [doi:10.1093/ofid/ofx258]

  • Peters L, Mocroft A, Grint D, Moreno S, Calmy A, Jevtovic D, Sambatakou H, Lacombe K, De Wit S, Rockstroh J, Smidt J, Karpov I, Grzeszczuk A, Haziosmanovic V, Gottfredsson M, Radoi R, Kuzovatova E, Orkin C, Ridolfo AL, Zapirain J, Lundgren J.

    Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study.

    ANTIVIRAL THERAPY . 23(5): 405-413.

    [doi:10.3851/IMP3218]

  • Rosado-Sánchez I, Herrero-Fernández I, Tarancon-Diez L, Moreno S, Iribarren JA, Dalmau D, Vera-Méndez F, Leal M, Pacheco YM.

    Increased frequencies of Th17 cells and IL17a-producing regulatory T-cells preceding the immunodiscordant response to antiretroviral treatment.

    JOURNAL OF INFECTION . 76(1): 86-92. Nº de citas: 6

    [doi:10.1016/j.jinf.2017.10.010]

  • Serrano-Villar S, Moreno S, Ferrer M.

    The functional consequences of the microbiome in HIV: insights from metabolomic studies.

    CURRENT OPINION IN HIV AND AIDS . 13(1): 88-94. Nº de citas: 7

    [doi:10.1097/COH.0000000000000430]

  • Caniglia EC, Phillips A, Porter K, Sabin CA, Winston A, Logan R, Gill J, Vandenhende MA, Barger D, Lodi S, Moreno S, Arribas JR, Pacheco A, Cardoso SW, Chrysos G, Gogos C, Abgrall S, Costagliola D, Meyer L, Seng R, van Sighem A, Reiss P, Muga R, Hoyos SP, Braun D, Hauser C, Barrufet P, Leyes M, Tate J, Justice A, Hernán MA.

    Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 77(1): 102-109. Nº de citas: 2

    [doi:10.1097/QAI.0000000000001562]

  • Vivancos Gallego MJ, Moreno Zamora A, Quereda Rodríguez-Navarro C.

    Treatment of hepatitisC virus with direct-acting antivirals: Practical aspects and current situation.

    REVISTA CLINICA ESPANOLA . 218(1): 29-37. Nº de citas: 1

    [doi:10.1016/j.rce.2017.07.006]

  • Aguado JM, Silva JT, Fernández-Ruiz M, Cordero E, Fortún J, Gudiol C, Martínez-Martínez L, Vidal E, Almenar L, Almirante B, Cantón R, Carratalá J, Caston JJ, Cercenado E, Cervera C, Cisneros JM, Crespo-Leiro MG, Cuervas-Mons V, Elizalde-Fernández J, Fariñas MC, Gavaldà J, Goyanes MJ, Gutiérrez-Gutiérrez B, Hernández D, Len O, López-Andujar R, López-Medrano F, Martín-Dávila P, Montejo M, Moreno A, Oliver A, Pascual A, Pérez-Nadales E, Román-Broto A, San-Juan R, Serón D, Solé-Jover A, Valerio M, Muñoz P, Torre-Cisneros J, Spanish Society of Transplantation (SET), Group for Study of Infection in Transplantation of the Spanish Society of Infect, Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016).

    Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

    TRANSPLANTATION REVIEWS . 32(1): 36-57. Nº de citas: 69

    [doi:10.1016/j.trre.2017.07.001]

  • Vivancos-Gallego MJ, Jiménez-López MÁ, Gioia F, Ibañez-Segura D, Romero-Vivas J, Cobo J.

    A scoring system for prescribing fidaxomicin in Clostridium difficile infection

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 36(1): 34-37. Nº de citas: 2

    [doi:10.1016/j.eimc.2016.07.013]

  • Navarro D, San-Juan R, Manuel O, Giménez E, Fernández-Ruiz M, Hirsch HH, Grossi PA, Aguado JM, ESGICH CMV Survey Study Group, on behalf of the European Study Group of Infectio.

    Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.

    TRANSPLANT INFECTIOUS DISEASE . 19(6): . Nº de citas: 18

    [doi:10.1111/tid.12773]

  • Ponte-Sucre A, Gamarro F, Dujardin JC, Barrett MP, López-Vélez R, García-Hernández R, Pountain AW, Mwenechanya R, Papadopoulou B.

    Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.

    PLOS NEGLECTED TROPICAL DISEASES . 11(12): . Nº de citas: 368

    [doi:10.1371/journal.pntd.0006052]

  • Monge-Maillo B, Chamorro Tojeiro S, López-Vélez R.

    Management of osseous cystic echinococcosis.

    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY . 15(12): 1075-1082. Nº de citas: 10

    [doi:10.1080/14787210.2017.1401466]

  • Serrano-Villar S, Caruana G, Zlotnik A, Pérez-Molina JA, Moreno S.

    Effects of Maraviroc versus Efavirenz in Combination with Zidovudine-Lamivudine on the CD4/CD8 Ratio in Treatment-Naive HIV-Infected Individuals.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 61(12): . Nº de citas: 10

    [doi:10.1128/AAC.01763-17]

  • Serre-Delcor N, Treviño B, Monge B, Salvador F, Torrus D, Guitérrez B, López-Vélez R, Soriano-Arandes A, Sulleiro E, Goikoetxea J, Pérez-Molina JA, Grupo de trabajo de +REDIVI.

    Eosinophilia prevalence and related factors in travel and immigrants of the network +REDIVI.

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 35(10): 617-623. Nº de citas: 4

    [doi:10.1016/j.eimc.2016.02.024]

  • Serrano-Villar S, Hernández-Novoa B, de Benito A, Del Romero J, Ocampo A, Blanco JR, Masiá M, Sendagorta E, Sanz G, Moreno S, Pérez-Molina JA.

    Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM.

    Plos One . 12(11): . Nº de citas: 10

    [doi:10.1371/journal.pone.0188851]

  • López-Sanromán A, Rodríguez de Santiago E, Cobo Reinoso J, Del Campo Moreno R, Foruny Olcina JR, García Fernández S, García García de Paredes A, Aguilera Castro L, Ferre Aracil C, Albillos Martínez A.

    Results of the implementation of a multidisciplinary programme of faecal microbiota transplantation by colonoscopy for the treatment of recurrent Clostridium difficile infection.

    GASTROENTEROLOGIA Y HEPATOLOGIA . 40(9): 605-614. Nº de citas: 2

    [doi:10.1016/j.gastrohep.2017.03.004]

  • Palacios-Baena ZR, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale P, Oliver A, Pintado V, Gasch O, Martínez-Martínez L, Pitout J, Akova M, Peña C, Molina Gil-Bermejo J, Hernández A, Venditti M, Prim N, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Giamarellou H, Almela M, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Paño-Pardo JR, Torre-Cisneros J, Souli M, Bonomo RA, Carmeli Y, Paterson DL, Pascual Á, Rodríguez-Baño J, Spanish Network for Research in Infectious Diseases (REIPI)/European Study Group.

    Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum ß-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort.

    CLINICAL INFECTIOUS DISEASES . 65(10): 1615-1623. Nº de citas: 35

    [doi:10.1093/cid/cix606]